Ochre Bio announces partnership with Boehringer Ingelheim to develop novel regenerative treatments for patients with advanced ...

Boehringer Ingelheim will apply Ochre Bio’s discovery platform to develop treatments for late-stage metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis and other chronic liver diseases ...

In a deal that could exceed $1 billion for Ochre Bio Ltd., the U.K.-based liver disease therapy developer will collaborate with Boehringer Ingelheim GmbH. In the meantime, Hepion Pharmaceuticals Inc.

Of course, this is the ochre jelly of Dungeons & Dragons. However, creatures like this can be difficult for both new and veteran dungeon masters as it offers a bit of a stranger playstyle and ...

Boehringer is committing to pay Ochre Bio to up to $35 million to begin the partnership, which is focused on identifying, characterizing, and validating multiple novel regenerative targets for ...

Boehringer Ingelheim signed a $1.3 billion deal with Ochre Bio to develop treatments for chronic liver diseases (CLD), including metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis, ...

Coastal color palettes have come a long way from the world of the classic blue and white nautical stripe, and designers are ...

Ramirez. It runs May 2-26. Polly Maynard portrays half of an alcoholic Brooklyn couple in artistic director Matthew Posey's ...

PATTI & THEO, a new dark comedy written and directed by Matthew Posey, opens May 1 at the Ochre House Theater in Dallas.

Jack O’Meara’s Oxford based life-sciences company uses machine learning to develop RNA therapies for a range of chronic ...

Turner Prize winner Helen Cammock is the latest to join a list of luminaries whose work features in a public art trail across East London. The Line, a free outdoor exhibition that runs from Stratford ...